Design of a protein signature predicting response to neo-adjuvant treatment with chemotherapy combined with bevacizumab in breast cancer patients

Category Primary study
JournalAnnals of Oncology
Year 2019
This article has no abstract
Epistemonikos ID: f28c5435d550582f4150710d5732df0da89511d8
First added on: Feb 10, 2025